Ligustilide.

Taking the root and the isolated compound together is the same input from two directions, and the root also supplies ferulic acid and polysaccharides that the isolate does not. How much of the compound a given root preparation actually delivers depends heavily on drying, storage and whether the preparation was a decoction or an oil extract. Counting them as separate additions overstates the total.

This is one of the oldest and most used fixed pairs in Chinese herbal practice, and the studies available on it tested the pair rather than either herb alone. The pairing is a formulation convention with centuries of precedent behind it. What it does in people has not been separated from what either herb does alone.

The compound dissolves in oil, not water, so a lipid carrier is what makes a repeatable dose possible at all. Medium-chain triglycerides are the usual choice because they stay liquid, resist rancidity and disperse well in a softgel. This is a delivery decision, not an activity claim.

Tocopherols interrupt the lipid peroxidation chain in the oil phase, which slows the oxidation and dimerisation that destroy this compound on the shelf. Nearly every stable oil-based preparation includes one. The tocopherol is doing a job in the bottle, and any effect after ingestion is a separate question.

Licorice is the conventional harmonising herb in these formulas and also acts as a natural emulsifier through its saponin content, which helps disperse oily constituents in a water decoction. The pairing is formulation convention with a plausible physical basis. Note that licorice carries its own blood pressure and potassium considerations at sustained doses, independent of anything here.

Phospholipids form mixed micelles that carry oil-soluble compounds into a dispersible form, which smooths out the erratic uptake of a compound that otherwise depends on whether a meal contained fat. This is standard formulation practice for volatile oil constituents. The lecithin contributes nothing pharmacologically at these amounts.

Ginger commonly accompanies Angelica in classical preparations, and its own oleoresin fraction shares the lipophilic behaviour that governs delivery here. Whether the two do anything together beyond travelling in the same lipid phase has not been separated out. Regard this as formulation lineage rather than demonstrated interaction.

Angelica and chuanxiong preparations have been reported in preclinical work to reduce platelet aggregation, and nattokinase acts on fibrin. Stacking two agents that both point in the same direction on clotting is worth flagging even though neither effect is well quantified in people for the isolated compound. Anyone on anticoagulant or antiplatelet medication should raise this pairing with their prescriber.

Long-chain polyunsaturated fats are themselves highly oxidisable, so co-formulating them with an oxidation-prone phthalide puts two unstable species in the same oil phase competing for the same antioxidant protection. That is a stability problem before it is anything else. The shared platelet consideration applies here as well.